Research theme for competitive and other funds (2)：
2022 - 2025 化学療法感受性規定因子SLFN11制御による膠芽腫新規治療法の開発
2017 - 2022 New therapy for recurrent glioblastoma, EUrd-CED
Papers (70)：
Takahiro Watanabe, Shinichi Noto, Manabu Natsumeda, Shinji Kimura, Fumie Ikarashi, Satoshi Tabata, Mayuko Takano, Yoshihiro Tsukamoto, Makoto Oishi. Improvements in activities of daily living among patients with brain tumors are associated with age, baseline physical function, duration of rehabilitation, and tumor recurrence but not type. International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation. 2024
Manabu Natsumeda, Satoshi Shibuma, Haruhiko Takahashi, Jotaro On, Yoshihiro Mouri, Kaoru Tomikawa, Hidemoto Fujiwara, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, et al. Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature. Brain Tumor Pathology. 2024. 41. 2. 85-91
Yasuo Sugita, Takuya Furuta, Satoru Komaki, Junko Miyoshi, Koichi Ohshima, Hideyuki Abe, Yoshihiro Tsukamoto, Hitoshi Takahashi, Akiyoshi Kakita. The perivascular microenvironment in primary central nervous system Epstein-Barr virus-positive lymphomas: the role of PD-1 and PD-L1. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2017. 76. 6. 537-537
